Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

Oldgren Jonas; Steg Philippe Gabriel; Hohnloser Stefan H.; Lip Gregory Y. H.; Kimura Takeshi; Nordaby Matias; Brueckmann Martina; Kleine Eva; ten Berg Jurrien M.; Bhatt Deepak L.; Cannon Christopher P.

首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

【24h】

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

机译：Dabigatran双重治疗用冠状动脉介入在心房颤动患者中有或没有急性冠状动脉综合征的经皮冠状动脉介入作用：亚组分析来自重新双PCI试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims After percutaneous coronary intervention (PCI) in patients with atrial fibrillation, safety and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of patients undergoing PCI due to acute coronary syndrome (ACS) or elective PCI, and those receiving ticagrelor or clopidogrel treatment.

机译：在经皮冠状动脉介入（PCI）后的心房颤动，由于急性冠状动脉综合征（ACS）或选择性PCI，对PCI的预先指定亚组评估了与达比胍双重治疗的安全性和有效性，以及接受TICAGRELOR或CLOPIDOGREL的患者治疗。

著录项

来源
《European Heart Journal: The Journal of the European Society of Cardiology》 |2019年第19期|共11页
作者
Oldgren Jonas; Steg Philippe Gabriel; Hohnloser Stefan H.; Lip Gregory Y. H.; Kimura Takeshi; Nordaby Matias; Brueckmann Martina; Kleine Eva; ten Berg Jurrien M.; Bhatt Deepak L.; Cannon Christopher P.;
展开▼
作者单位

Uppsala Univ Uppsala Clin Res Ctr Dag Hammarskjolds Vag 38 SE-75185 Uppsala Sweden;

Univ Paris Diderot FACT F CRIN Network INSERM U 1148 F-75018 Paris France;

Goethe Univ Frankfurt Dept Med Div Cardiol Theodor Stern Kai 7 DE-60590 Frankfurt Germany;

Univ Birmingham Inst Cardiovasc Sci Birmingham B15 2TT W Midlands England;

Kyoto Univ Dept Cardiovasc Med Sakyo Ku 54 Shogoin Kawahara Cho Kyoto 6068507 Japan;

Boehringer Ingelheim Int GmbH TA CardioMetab Binger Str 173 D-55216 Ingelheim Germany;

Boehringer Ingelheim Int GmbH TA CardioMetab Binger Str 173 D-55216 Ingelheim Germany;

Boehringer Ingelheim Int GmbH TA CardioMetab Binger Str 173 D-55216 Ingelheim Germany;

St Antonius Hosp Dept Cardiol Koekoekslaan 1 NL-3435 CM Nieuwegein Netherlands;

Brigham &

Womens Hosp Heart &

Vasc Ctr 75 Francis St Boston MA 02115 USA;

Brigham &

Womens Hosp Heart &

Vasc Ctr 75 Francis St Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Atrial fibrillation; Acute coronary syndrome; Coronary artery disease; Percutaneous coronary intervention; Oral anticoagulants; P2Y12 inhibitors;

机译：心房颤动;急性冠状动脉综合征;冠状动脉疾病;经皮冠状动脉介入;口服抗凝剂;P2Y12抑制剂;

相似文献

外文文献
中文文献
专利

1. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial [J] . Oldgren Jonas, Steg Philippe Gabriel, Hohnloser Stefan H., European Heart Journal: The Journal of the European Society of Cardiology . 2019,第19期

机译：Dabigatran双重治疗用冠状动脉介入在心房颤动患者中有或没有急性冠状动脉综合征的经皮冠状动脉介入作用：亚组分析来自重新双PCI试验
2. Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention [J] . Oldgren Jonas, Steg Philippe-Gabriel, Hohnloser Stefan H., Circulation: An Official Journal of the American Heart Association . 2017,第24期

机译：来自重新双重PCI试验的亚组分析：对达比甙患者进行心房颤动患者进行经皮冠状动脉介入的患者双抗血栓疗法
3. Dual Anti-Thrombotic Therapy With Dabigatran After Percutaneous Coronary Intervention in Atrial Fibrillation - Japanese and East-Asian Subgroup Analysis of the RE-DUAL PCI Trial - [J] . Ako Junya, Okumura Ken, Nakao Koichi, Circulation journal . 2019,第2期

机译：在心房颤动经皮冠状动脉介入后与Dabigatran进行双重抗血栓形成治疗 - 日本和东亚亚组分析重新双重PCI试验 -
4. Evaluation of Matrix Metalloproteinase-9 (MMP-9) and its tissue inhibitor of metalloproteinase-1 (Timp-1) in patients with coronary syndromes after percutaneous intervention(PCI) [C] . Revnic F., Revnic C.R., Nica A., International Congress on Coronary Artery Disease . 2011

机译：经皮干预后冠状动脉综合征患者中基质金属蛋白酶-9（MMP-9）及其组织抑制剂及其组织抑制剂（PCI）
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial [O] . Jonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, -1

机译：在有或没有急性冠脉综合征的房颤患者中经皮冠状动脉介入治疗后达卡加群与替格瑞洛或氯吡格雷双重治疗：RE-DUAL PCI试验的亚组分析
7. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial [O] . Jonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, 2019

机译：Dabigatran双重治疗用TiCagrelor或Clopidogrel在心房颤动的心房颤动或没有急性冠状动脉综合征的患者中的经皮冠状动脉介入作用：来自重新双PCI试验的亚组分析

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

摘要

著录项

相似文献

相关主题

期刊订阅